There has been an ‘atypical’ rotation of stocks since the announcement of the COVID-19 vaccine trials with companies with the ...
Stocks that were doing well during the pandemic are unlikely to reverse when a vaccine has been developed as consumers ...
Platinum International Health Care manager Bianca Ogden is well placed to benefit from the COVID-19 vaccine trials as her fund ...
As Moderna becomes the second firm to announce a successful COVID-19 vaccine trial, its shares have risen by more than ...
Outsider regrets to say that his extensive portfolio of investments does not include pharmaceutical giant Pfizer which at the time ...
There could be ‘losers’ from the creation of a COVID-19 vaccine as a return to normal life could be negative ...
Markets, which are already in a bullish mood due to the incoming Biden administration, are overthinking the positive vaccine news, ...
After announcing it is producing a COVID vaccine, Money Management looks at which funds have the highest allocation to the ...
In financial markets, excitement drives headlines. Equity markets rise, fall, and recover — creating stories that capture attention. Yet sustainable...
Winner of Executive of the Year – Funds Management 2025After years at Goldman Sachs and Credit Suisse, Jonathan Belz founded...
Cryptocurrency liquidity has become a cornerstone of sophisticated wealth management strategies, with real-time settlement capabilities revolutionizing traditional investment approaches. The...
In this episode of Relative Return, host Laura Dew chats with Roy Keenan, co-head of fixed income at Yarra Capital...
